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A B S T R A C T
Pleurotus sajor-caju (PSC) is an edible mushroom used in food supplements, presenting antitumor properties
through induction of cell death pathways. The PSC potential against colorectal cancer was analyzed by exposing
HCT116wt cells to different PSC extracts. The PSC n-hexane extract (PSC-hex) showed the highest cytotoxicity
effect (IC50 value 0.05 mg/mL). The observed cytotoxicity was then associated to apoptosis-promoting and cell
cycle-arrest pathways. PSC-hex was able to induce apoptosis related to breakdown of mitochondrial membrane
potential and ROS generation. The absence of cytotoxicity in HTC116-p53 and HTC116-Bax cells, alongside with
an increase in p53, Bax and Caspase-3 expression, and decrease in Bcl-2 expression, supports that the pro-
apoptotic effect is probably induced through a p53 associated pathway. PSC-hex induced cell cycle arrest at G2/
M in HCT116wt without cytotoxicity in HTC116-p21 cells. These findings suggest that a p21/p53 cell cycle reg-
ulation pathway is probably disrupted by compounds present on PSC-hex. Identification of the major compo-
nents was then performed with ergosta-5,7,22-trien-3β-ol representing 30.6% of total weight. In silico docking
studies of ergosta-5,7,22-trien-3β against Bcl-2 were performed and results show a credible interaction with the
Bcl-2 hydrophobic cleft. The results show that PSC-hex can be used as supplementary food for adjuvant therapy
in colorectal carcinoma.
1. Introduction
Colorectal cancer (CRC) is the third most common type of cancer
and fourth leading cause of cancer death in the world as about 690,000
people annually die for this disease (Arnold et al., 2017). Clinically,
chemotherapy and radiation are commonly used before or after sur-
gery, even so 40% of all patients develop metastasis and presented
recidives (Bahrami et al., 2018). CRC is classified by its clin-
icopathological characteristics, but clinical outcomes and drugs re-
sponse, molecular characteristics and prognosis are uncertain and het-
erogeneous (Rodriguez-Salas et al., 2017). The molecular changes
associated to tumor progression are attributable to genomic instability
that shows common alteration of critical pathways. These include TP53,
PI3CA, TGF-β, and Epithelial-to-mesenchymal transition (EMT) genes.
These molecular events allows modifications such as loss of control of
cell growth, increases cell-survival and cell-proliferation, promotes in-
vasion, inhibits apoptosis, promotes epithelial to mesenquimal-transi-
tion and angiogenesis (Rodriguez-Salas et al., 2017).
The identification of consensus molecular subtypes (CMS) have
clinical relevance independent of cancer stage and is heavily influenced
by the tumor microenvironment, are divided into CMS1 (MSI immune),
CMS2 (canonical), CMS3 (metabolic) and CMS4 (mesenchymal). These
CMS subtypes are represented in vitro model systems, providing re-
source for preclinical studies in CRC (Berg et al., 2017). CMS4 tumors
tended to be diagnosed at more advanced stages (III and IV), and one of
the cell lines representing in vitro this subtype is HCT116.
Therefore there is a constant demand to investigate new and ef-
fective anti-CRC drugs to improve survival while maintaining health-
related quality of life (Quidde et al., 2016; Rejhová et al., 2017). Diet
appears to be one of the ways by which carcinogenic agent instigate the
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DNA repair modulating the intensity of early carcinogenic events
(Rejhová et al., 2017). Several natural chemopreventive food com-
pounds are being evaluated as edible and medicinal supplements, in-
cluding the ones found in mushrooms, with antitumor substances al-
ready been identified in many species (Alonso et al., 2017; Gogavekar
et al., 2014; Jin et al., 2016; Santesso and Wieland, 2016). Anti-
proliferative activity of Pleurotus sajor-caju (Fr) Singer extracts against
human tumor cell lines (Hep-2, HeLa, Sarcoma 180, among others) has
been reported (Assis et al., 2013). There is a major interest in the use of
mushrooms and/or extracts as dietary supplements, given the beneficial
properties as enhancers of immune function and promoters of health
(Lo et al., 2012; Roncero-Ramos and Delgado-Andrade, 2017; Tanaka
et al., 2016).
Different molecules found in fruiting bodies have been reported to
present antitumor potential (Greeshma et al., 2016; Ren et al., 2012).
Some examples are polysaccharides, glycoproteins, proteoglycans,
proteins, quinones, cerebrosides, isoflavones, catechols, triacylgly-
cerols, phenolic acids, terpenes, and steroids (Ferreira et al., 2010;
Villares et al., 2012). Evidences support the theory of antitumoral
properties of sterols, including inhibition of tumor growth and stimu-
lation of apoptosis (Kikuchi et al., 2017). According to Barreira and
Ferreira (2015), the mechanism underlying the inhibition of cell growth
could be similar to the mechanism associated with protein kinase C
activity. Understanding the mechanism of apoptosis has important
implications in the prevention and treatment of many diseases, in
particular cancer. The Bcl-2 family of proteins are apoptotic regulators
that control cell survival (Opferman and Kothari, 2018).
So, it is important to explore how Pleurotus sajor caju (PSC) con-
stituents may regulate the cell dynamics and reduce cell proliferation.
Identification of isolated compounds or extracts that induce the apop-
totic cascade to reduce proliferation rates of cancer cells would be an
effective strategy to control cancer progression (Venkatesh Gobi et al.,
2018). The aim of this study was to investigate the effect of PSC ex-
tracts, specifically the PSC n-hexane extract (PSC-hex) in the pro-
liferation of colorectal cancer cells (HCT116wt, -Bax, -p21 and –p53), and to
correlate the observed anti-proliferation activity to activation of pro-
apoptotic and/or cell arrest regulation pathways. To verify cell se-
lectivity, MRC-5 cell line was used, a lung fibroblast cell line origin that
is associated with the initiation of epithelial-mesenchymal transition
and metastasis. The identification of the main PSC -hex components
was also obtained, and in silico docking studies were performed to
provide clues on the potential mechanism of action of the PSC n-hexane
extract by the inhibition of the Bcl-2, an anti-apoptotic protein.
2. Material and methods
2.1. Experimental materials
Trypsin and RNase A were from Gibco Invitrogen Co. (Paisley, UK).
Dulbecco's Modified Eagle Medium (DMEM) and fetal bovine serum
(FBS) were acquired from Hyclone Lab Inc. (USA). Acetic acid, di-
methylsulfoxide (DMSO), propidium iodide (PI) and phenolic standards
were from Sigma Chemical Co. (St. Louis, USA). DiOC6(3) (3,3′-
Dihexyloxacarbocyanine Iodide (TermoFisher, Eugene,OR).
Dichlorodihydrofluorescein (DCFH) and DAPI 4′,6-diamidino-2-pheny-
lindole were purchased from Sigma-Aldrich (St. Louis, USA).
Tricloroacetic acid (TCA) and Tris-Base were from Merck (Darmstadt,
Germany). Folin-Ciocalteu's phenol reagent (Merck) was used for the
determination of total phenols. All standards were purchased from
Sigma-Aldrich, FITC Annexin V Apoptosis Detection Kit (Sigma-Aldrich,
MO, USA), anti-Bax (Abcam, 1:500), anti-BCl-2 (Abcam, 1:500), anti-
caspase-3 (Abcam, 1:500), anti-β-actin (Abcam, 1:1000), Human
Apoptosis Antibody Array Kit (Abcam).
2.2. Sample preparation
Samples of Pleurotus sajor-caju fruiting bodies (edible mushrooms)
were collected in farm located 29°09′48.9″S 51°36′56.5″W, at Rio
Grande do Sul state, in the southern region of Brazil, in autumn 2015.
The extracts were obtained using an ultrasonic device (QSonica soni-
cators, model CL-334, Newtown, CT, USA), comprising an ultrasound
power of 500W, at a frequency of 20 kHz, equipped with a digital
timer, following a protocol previously described by Heleno et al.
(2016). The lyophilized powdered samples (10 g) were extracted with
100mL of each selected solvent (n-hexane, chloroform, ethyl acetate,
ethanol and ethanol/water (1:1, v/v)) into the ultrasonic device at the
temperature of 20 °C, for 30min. After extraction, the mixture was
filtered and the solvent lyophilized. For the cytotoxicity assay, five
dried extracts obtained were dissolved in ethanol/water (25:75, v/v).
2.3. Cell culture
HCT116wt and MRC-5 cells were acquired from ATCC (American
Type Culture Collection, United States), and HCT116-Bax, HCT116-p21,
HCT116-p53 were supplied by Dr. Annette K. Larsen (Laboratory of
Cancer Biology and Therapeutics, Paris, France). All the reagents were
of ultrapure grade. Water was treated in a Milli-Q water purification
system (TGI Pure Water Systems, USA). HCT116wt (human colorectal
carcinoma), HCT116-Bax, HCT116-p21, HCT116-p53 and MRC-5
(Fibroblast lung) were routinely maintained as adherent cell cultures in
DMEM medium with 10% heat-inactivated FBS, in a humidified in-
cubator at 37 °C with 5% CO2. Cell cultures were periodically tested for
Mycoplasma contamination. HCT116 cell lines were authenticated at
DNA Diagnostics Center (DDC) from Public Health England (PHE) using
short tandem repeat (STR) methodology and reference sample com-
parison to ATCC STR profile database. All assays were performed with
cells in exponential growth, with viabilities over 90% and repeated at
least in three independent experiments.
2.4. Cell viability (MTT assay)
All cells were evaluated according to the procedure adopted in the
NCI's (National Cancer Institute) in vitro anticancer drug screening,
which uses MTT assay to assess cell survival (Denizot and Lang, 1986).
Briefly, the cell line was plated at an appropriate density (5×104 cells/
well) in 96-well plates and allowed to attach for 24 h. Cells were then
treated for 24 h with various concentrations of the extracts. Following
this period, the adherent cells were incubated with MTT for 2 h. The
crystal formazan was solubilized with DMSO and the absorbance was
Fig. 1. Results the cytotoxic effect from MTT assay after 24 h incubation for the different
extracts in HCT116wt, HCT116-Bax, HCT116-p53 and HCT116-p21 cell lines and lung human
cell line (MRC-5). Data are the mean ± S.D. of three independent experiments. *
p < .05 versus control.
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measured at 540 nm in a microplate reader SpectraMAX M2/M2e
(Molecular Devices, USA). The anti-proliferative activity of the com-
pounds was inferred from the MTT assay by comparing the absorbance
of the wells containing extract-treated cells with the absorbance of the
wells containing untreated cells (Tolosa et al., 2015). Three to six in-
dependent experiments were performed in duplicate, the results were
expressed as mean values ± standard deviation (SD) and IC50 (dose
causing 50% cell death).
2.5. Acridine orange/ethidium bromide staining
The changes in chromatin organization, apoptotic cells or frag-
mented nuclei upon treatment with PSC-hex was determined micro-
scopically by acridine/orange-ethidium bromide (AO-EB) dual staining.
HCT116 cells (7× 104 cell/well) were grown in 24-well plates. After
24 h of extract treatment, the cells were detached and the suspension
from each well was separated in vials. The vials were centrifuged at
1200 rpm for 5min. The pellet obtained was washed once with PBS,
stained with AO/EB solution with 25 μL PBS and 2 μL AO/EB dye, in-
cubated for 5min, and observed under fluorescence microscope (BX43 -
Olympus). Morphological changes were determined according to
Pajaniradje et al. (2014).
2.6. ROS accumulation and mitochondrial membrane potential (Δψm)
measurement
Reactive Oxygen Species (ROS) generation was analyzed by flow
cytometry using DCFH-DA. Cells were treated with PSC-hex for 24 h,
suspended in PBS and incubated with 10 μM DCFH-DA at 37 °C for
30min. Fluorescence generation due to the hydrolysis of DCFH-DA to
dichlorodihydrofluorescein (DCFH) by non-specific cellular sterases,
and the subsequent oxidation of DCFH by peroxides was measured by
means of flow cytometry (BD FACScalibur, San Jose, California). The
uptake of the cationic fluorescent dye 3,3′-dihexyloxacarbocyanine io-
dide (DiOC6(3)) (2 μL of 2 μmol/L stock solution in dimethyl sulfoxide
[DMSO]) was used for the evaluation of mitochondrial membrane po-
tential (Aranda et al., 2013). Cell treatment was performed as in ROS
experiments. Untreated controls and treated cells were harvested and
washed twice with PBS. The cell pellets were then re-suspended in 2mL
of fresh incubation medium containing DiOC6 and incubated at 37 °C in
a thermostatic bath for 30min. HTC116 cells were separated by cen-
trifugation, washed twice with PBS, and analyzed by flow cytometry
using FL1 channel (488/533 nm) (BD FACScalibur, San Jose, Cali-
fórnia) (Wlodkowic et al., 2009).
2.7. Apoptosis and cell cycle analysis by flow cytometry
Induced apoptosis was assayed by the Human Annexin V-FITC/PI
apoptosis Kit (Sigma-Aldrich, MO, USA), according to the manufac-
turer's instructions. The fraction of the cell population in different
quadrants was measured using quadrant statistics with the FlowJo 10.0
software (LLC, Ashland, Ore). For the analysis of cell cycle phase dis-
tribution, HCT116wt cells were plated at 1.5× 105 cells/mL in 6-well
plates and left incubating for 24 h. Cells were then incubated with
complete medium only, medium with the control solvent ethanol/water
(25:75 v/v) or with PSC-hex at IC50 (0.05mg/mL) and half IC50
(0.025mg/mL), previously determined by the MTT assay (Monks et al.,
1991). Cells were harvested following 24 h incubation with the extract
and further processed for either cell cycle analysis or apoptosis detec-
tion. For cell cycle analysis, cells were fixed in 70% ethanol for
10min at room temperature. After centrifugation cells were incubated
with PI (5 μg/mL) and RNase A in PBS (100 μg/mL) for 30min on ice
(Pozarowski and Darzynkiewicz, 2004). Cellular DNA content (for cell
cycle distribution analysis and presence of sub-G1 peak, suggestive of
Fig. 2. Results dual stain OA/EB and Giemsa in HCT116wt cell line. (A). Negative control (ethanol) group: circular green nucleus uniformly distributed in the center of the cell. (B) PSC
0.025mg/mL (early apoptotic cells): nucleus showed yellow-green fluorescence staining and concentrated into a crescent or granular shape. (C) PSC 0.05mg/mL (late apoptotic cells):
the nucleus of cell showed orange or red fluorescence staining and gathered in concentration and located in bias and necrotic cells volume was increased, showing uneven red
fluorescence and an unapparent outline. and the color observed after fluorescence staining in red indicate late apoptosis and yellow early events of apoptosis. (For interpretation of the
references to color in this figure legend, the reader is referred to the Web version of this article.)
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apoptosis induction) and measurement of phosphatidylserine ex-
ternalization were analyzed using FL1 channel (488/533 nm) and FL3
channel (488/670 nm) an BD FACScalibur, San Jose, Califórnia, plot-
ting at least 10,000 events per sample (Pietkiewicz et al., 2015). Three
to six independent experiments were performed in duplicate and the
results were expressed as mean values ± standard deviation (SD). ρ
values < 0.05 were considered as statistically significant.
2.8. Apoptosis antibody array membranes analysis
Relative levels of 43 human apoptosis-related proteins were de-
tected and analyzed using a human array kit, according to the manu-
facturer's instructions (Abcam, #ab134001). Briefly, the membrane
containing immobilized apoptosis-related antibodies was blocked with
bovine serum albumin for 2 h on a rocking platform at room tempera-
ture. The membrane was then incubated with lysates of untreated or
treated HCT116wt cells (IC50), along with Detection Antibody Cocktail
overnight at 2 °C to 8 °C. The membrane was incubated with strepta-
vidin horseradish peroxidase conjugate followed by chemiluminescent
detection reagent. The membrane was scanned using ImageQuant LAS
500 (GE Healthcare life sciences). According Schneider et al. (2012) the
pixel density in each spot volume was determined, corrected for
background and expressed as fold change (treated vs. untreated cells)
using ImageJ version 1.46 software (NIH, Bethesda, MD; http://imagej.
nih.gov/ij). Protein Array Analyzer plugin (available at im-
age.bio.methods.free.fr/ImageJ/?Protein-Array-Analyzer-for-Im-
ageJ.html, last accessed Oct 8, 2015) (Carpentier, 2014).
2.9. Western blotting analysis
To evaluate the expression levels of intracellular proteins related to
apoptosis, HCT116wt cells were treated with PSC-hex (IC50) for 24 h. For
the isolation of total protein fractions, the cells were collected, washed
twice with ice-cold PBS, and lysed using cell lysis buffer (NP40, 20mM
Tris pH 7.5, 150mM NaCl, 1% Triton X-100, 2.5mM sodium pyr-
ophosphate, 1 mM EDTA, protease inhibitor). The lysates were col-
lected by scraping from the plates and then centrifuged at
10,000 rpm at 4 °C for 5min. Total protein samples were loaded on a
12% of SDS polyacrylamide gel electrophoresis and transferred onto
polyvinylidene fluoride (PVDF) membrane (Millipore, Billerica, MA,
USA) for 1 h. Membranes were blocked at room temperature for 1 h
with blocking solution (5% power milk in TBST). Next, the membranes
were incubated for 1 h at room temperature with antihuman Bcl-2
rabbit pAb (1:1000 dilution; Abcam), antihuman Bax rabbit pAb
(1:1000 dilution; Abcam), antihuman Caspase-3 rabbit pAb (1:500 di-
lution; Abcam) or antihuman β-actin mouse (1:1500). After washing,
the membranes were incubated for 1 h at room temperature with
horseradish peroxidase (HRP)-linked antimouse Ig (1:1000 dilution;
Amersham) for β-actin or HRP-linked antirabbit Ig (1:50,000 dilution;
Amersham) for Bax, Bcl-2 and Caspase-3. Immunoblots were performed
using ECL prime Western blotting detection kit (Amersham).
Chemiluminescence visualization and detection was performed using
ImageQuant LAS 500 (GE Healthcare life sciences).
Fig. 3. Apoptosis analysis in HCT116wt cells using annexin V-FITC/PI though cytometry analysis for control and treated samples. The early apoptotic events (Annexin+/PI-) are shown in
lower right quadrant (Q1) of each panel. Quadrant (Q3) represents Annexin+/PI + late stage of apoptosis/necrosis. A) Control; (B, C) treatment with 0.025 mg/mL and 0.05 mg/mL of
PSC respectively. D) Quantitative results from flow cytometry. Results are the mean ± SD of three to six independent experiments performed in duplicate. *Values statistically
significantly (P < .05) different when compared to blank.
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Fig. 4. Cell cycle distribution percentage of HCT116wt cells after treatment with different concentrations of PSC (B,C) compared to control (A). The results of the cell cycle distribution
analysis by flow cytometry were analyzed by ModFit. D) The percentages of cell populations of different cell cycle phases are shown. Results are the mean ± SD of three to six
independent experiments performed in duplicate. *Values statistically significantly (P < .05) different when compared to blank.
Fig. 5. Mitochondrial membrane potential of HCT116wt cells after treatment with extracts of mushrooms using DiOC6(3) staining through cytometry. Cells with decreased fluorescence
(increase to the left of the graph), present mitochondria depolarization A) Control; (B, C) treatment with 0.025mg/mL and 0.05mg/mL of PSC, respectively. Results are the mean ± SD
of three to six independent experiments performed in duplicate.
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2.10. Gas chromatography-mass spectrometry (GC-MS)
PSC-hex was chemically characterized by GC-MS after sample de-
rivatization. This process consisted on the derivatization of hydroxyl
and carboxyl groups of the extracted compounds with 300 μL of N,O-bis
(trimethylsilyl)trifluoroacetamide (BSTFA; PanReac AppliChem,
Barcelona, Spain) by heating the resulting mixture at 70 °C for 1 h prior
to analysis. The derivatized sample was analyzed by GC-MS following a
protocol previously described by Falcão et al. (2016), consisting on a
Perkin Elmer system with a Clarus® 580 GC module and a Clarus® SQ
8 SMS module, equipped with DB-5MS fused-silica column
(30m×0.25mm i.d., film thickness 0.25 μm; J & W Scientific, Inc.).
Oven temperature was programmed, 45–175 °C, at 3 °C/min, subse-
quently at 15 °C/min up to 300 °C, and then held isothermal for 10min;
injector and detector temperatures were 280 °C. The transfer line tem-
perature was 280 °C; ion source temperature, 220 °C; carrier gas, he-
lium, adjusted to a linear velocity of 30 cm/s; split ratio, 1:40; ioniza-
tion energy, 70 eV; scan range, 40–300 u; scan time, 1 s. The software
Turbomass (software version 6.1.0, Perkin Elmer, Shelton, CT, USA) for
Windows was used for data acquisition. The identity of the components
was assigned by comparison of their retention indices, relative to C7-
C40 n-alkane indices and GC-MS spectra from a commercial MS data-
base (NIST).
2.11. Molecular docking
A Bcl-2 crystal structure was selected and obtained from the Protein
Data Bank (PDB entry: 4LXD). The Bcl-2 protein structure was prepared
for docking by removing all crystallized water molecules and the
Venetoclax inhibitor. AutoDockTools1.5.2 (ADT) (Morris et al., 2008)
was then used to assign polar hydrogens, add Gasteiger charges and
save the protein structure in PDBQT file format. A docking grid was
selected using ADT in order to encompass completely the ligand
binding site. The X,Y,Z grid center coordinates selected were 23.3, 32.7
and 13.1 respectively, and the X,Y,Z grid dimensions used were of 20 by
20 by 20 Å. The 2D structure of the studied sterol (Ergosta-5,7,22-trien-
3β-ol), was drawn using ACD/ChemSketch Freeware 12.0 software.
VegaZZ software was then used to perform 2D to 3D conversion and to
save the structures in PDB file format (Pedretti et al., 2004). Finally,
ADT was used to convert PDB to PDBQT file format. All docking si-
mulations were performed using AutoDock Vina software (Trott and
Olson, 2010), using an exhaustiveness parameter of 32. Docking
conformation analysis and image preparation was performed using
PyMOL software (Delano, 2002).
2.12. Statistical analysis
All of the data were expressed as mean ± SD. Differences between
groups were determined by using the Student's t-test, and different
groups were compared using one-way ANOVA followed by Tukey
multiple comparison to evaluate the differences between two groups
under multiple conditions. Statistical analysis was performed using
SPSS21.0 software. P < .05 was considered statistically significant.
3. Results and discussion
3.1. PSC extract exhibited anti-proliferative activity against the HCT116wt
cells
In order to evaluate the anti-proliferative activity of PSC, five cell
lines (HCT116wt, HCT116-Bax, HCT116-p21, HCT116-p53 and MRC-5)
were exposed to different concentration of PSC extracts for 24 h using a
variation of solvent polarity (hexane, chloroform, ethyl acetate, ethanol
and ethanol/water (1:1)). According Joana Gil-Chávez et al. (2013),
these organic solvents can be used for the extraction of both polar and
nonpolar compounds such as fatty acids, alkaloids, organochlorine,
phenols, aromatic hydrocarbons and oils, among others. As shown in
Fig. 1 a batch of different conditions crude extract were investigated.
The results revealed PSC n-hexane extraction as the most promising
condition, with an IC50 value of 0.05mg/mL in HCT116wt followed by
PSC acetone extract with an IC50 value of 0.2mg/mL. This result is
probably due to the amount of lipophilic compounds extracted in this
extract, corroborating with Sang et al. (2006) that they also presented
better activity against human cancer cells including colon carcinoma
(Caco-2), breast carcinoma (MCF-7) and acute myeloid leukemia (HL-
60) cells. The other extracts might require very high concentrations to
obtain the same effect as the n-hexane extract, which would make it
unusable.
Interestingly, while the PSC-hex was able to induce cytotoxic effects
on human colorectal carcinoma cells (HCT116wt), it showed practically
no anti-proliferative activity in non-tumor MRC-5 cells (Fig. 1). The
anticancer activity of the n-hexane extract was attributed to high sterol
content. Their selectivity may be related to inhibition of the mi-
tochondrial complex I, which according to Kalyanaraman et al. (2018),
Fig. 6. Cytometry evaluation indicating ROS formation in HCT116wt cells before and after extract exposition. Cells with increased fluorescence (increase to the right of the graph), present
accumulation of ROS A) Control; (B, C) treatment with 0.025mg/mL and 0.05mg/mL of PSC, respectively. Results are the mean ± SD of three to six independent experiments performed
in duplicate.
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lipophilic compounds may be a class of therapeutic drugs that inhibit
mitochondrial bioenergetics, mitochondrial respiration in tumor cells at
relatively non-toxic concentrations. These experiments suggest that the
PSC-hex promotes its cytotoxicity by inhibiting tumor-associated sig-
naling pathways. This assumption was tested by performing the same
experiments using HCT116 cell lines with deleted tumoral-associated
proteins: Bax (HCT116-Bax), p21 (HCT116-p21) and p53 (HCT116-p53).
The results were drastic, with no observed anti-proliferation activity on
any HCT-116 protein deficient cell lines, after exposure to PSC extracts
(Fig. 1). These results suggest that the PSC-hex components disrupt
multiple tumoral signaling pathways, including growth arrest (asso-
ciated to proteins p21 and p53) and/or apoptosis pathways (associated
to proteins Bax, Bcl-2 and p53). These results are in line with recent
findings, showed that many natural compounds found in mushrooms
have pro-apoptotic activities (Yang et al., 2016). Moreover, literature
supports that mushroom constituents such as sterols may contribute to
the antitumoral effects observed in this study (Heleno et al., 2015).
Considering these results, the follow up studies were all performed
using 0.05mg/mL (IC50 value) and 0.025mg/mL (half the IC50 value)
concentrations of the PSC-hex applied to HCT116wt adenocarcinoma
model cell line.
3.2. PSC-hex effect on apoptosis and cell cycle in HCT116wt
Apoptotic programmed cell death is characterized by various mor-
phological and biochemistry changes (Hird et al., 2015). To evaluate
the effect of PSC-hex in inducing apoptosis and changes in cell mor-
phology, the Giemsa and OA/EB staining protocol was used, after ex-
position of HCT116wt cells to 0.025 and 0.05mg/mL of extract con-
centration (Liu et al., 2015). Few early-stage apoptotic events were
Fig. 7. Modulation of apoptosis-related proteins before and after PSC extract exposition in HCT116wt cells treatment with 0.025 and 0.05mg/mL A) Pixel densities of apoptosis-related
proteins identified from array analysis of HCT116wt cell in response to treatment of 24 h at a concentration of 0.05 mg/mL, showing changes in levels of apoptosis protein compared to
untreated group *ρ < 0.05. B) Template demonstrating the location of spots of treated (below) and untreated (above) cell sample group representing the 43 apoptosis-related proteins
and location of the spots of the expression apoptosis-related proteins, C) Western blotting showing the expression levels of the proteins. For normalization of protein levels was used β-
actin loading control. Results are the mean ± SD of three to six independent experiments performed in duplicate. *Values statistically significantly (P < .05) different when compared
to blank.
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detected in the negative control (Fig. 2), while early-stages of apoptosis,
marked by crescent-shaped or granular yellow green AO nuclear
staining, were detected after cell exposition to 0.025mg/mL of the
extract (Fig. 2B). Late-stage of apoptosis, with condensation of chro-
matin, was observed after 0.05mg/mL exposition, as indicated by lo-
calized orange and red nuclear EB staining (Fig. 2 C). All necrotic cells
increased in volume and showed red fluorescence at their periphery.
To further analyze the effect of the PSC-hex in promoting apoptosis,
the Annexin V and PI staining assay was performed (Fig. 3). After ex-
position to PSC-hex, the number of HCT116wt cells in early apoptosis
increased from 0,45% (Fig. 3A, control), to 65,6% (Fig. 3C, 0.05mg/
mL); while the number of viable cells decreased from 92,2% (Fig. 3A,
control), to 25,9% (Fig. 3C, 0.05mg/mL). Both staining protocols
confirm that PSC-hex exerts the observed cytotoxicity, at least partially,
through a pro-apoptotic pathway.
Analysis of the effect of PSC-hex on HCT116wt cell cycle was also
performed by flow cytometry and results show an increase of cells in
the G2/M transition phase, with a concomitant decrease of cells in the
G1 and S-phases (Fig. 4). PSC-hex therefore seems to be an inducer of
G2/M cell cycle arrest. A significant accumulation of cells in the sub-G1
fraction was also observed, indicating that the extract induces apoptosis
(Fig. 4D).
3.3. PSC-hex activated depolarization of the mitochondrial membrane
potential and ROS accumulation in HCT116wt cells
The loss of Mitochondrial Membrane Potential (ΔΨm) is usually an
indicator of changes in the permeability of the mitochondrial mem-
brane, a process that is regulated by the Bcl-2 protein family (Ashkenazi
et al., 2017). In addition to the loss of ΔΨm, changes in permeability
can lead to the release of apoptosis factors such as cytochrome c, which
triggers the activation of caspase-9 followed by activation of effector
caspase-3, finally leading to apoptosis (Birkinshaw and Czabotar,
2017). The study of possible fluctuations in △Ψm in the presence of
PSC-hex was thus performed by flow cytometry, using the DiOC6(3)
stain protocol (Fig. 5). Compared with the untreated control (Fig. 5A),
both 0.025 and 0.05mg/mL PSC-hex concentrations (Fig. 5B–C) pro-
moted a decrease in fluorescence, indicating an induced ΔΨm depo-
larization in HCT116wt cells. These results suggest that PSC-hex might
be promoting apoptosis through pathways associated with increase in
mitochondrial permeability.
Cellular ROS production has been suggested as a possible cause for
ΔΨm depolarization and subsequent induction of apoptosis and cell
death (Chang et al., 2017). Many chemotherapeutic agents may be se-
lectively toxic to tumor cells, because they increase oxidant stress be-
yond tumor cell support (Lee et al., 2016). Previous studies indicate
that production of ROS is a relevant factor for regulating apoptosis (Al-
Khayal et al., 2017; Hu et al., 2016). To investigate if the mitochondrial
dysfunction observed in HCT116wt cells is promoted by ROS produc-
tion, a flow cytometry assay using DCF-DA stain was used to measure
ROS levels. As shown in Fig. 6, the levels of H2O2 and O2•− in cells
treated with 0.025mg/mL and 0.05mg/mL of PSC-hex, were elevated
by 3-fold and 2-fold respectively, compared to the untreated control
cells. These results indicate that apoptosis induced by PSC-hex may be
strongly associated with ROS accumulation.
3.4. Intrinsic signaling pathway modulated apoptosis in HCT116wt cells
To investigate the pathways by which PSC-hex may inducing
apoptosis in HCT116wt, we performed determination of apoptosis-re-
lated proteins using the Proteome Profiler Array (Human Apoptosis
Antibody Array Kit, Abcam, #ab13400). HCT116wt cells exposed to
0.05mg/mL of PSC-hex, showed a significantly altered expression
profile of apoptosis-related proteins. Increased expression was observed
for several apoptotic related proteins including Fas, HSP 60, HSP 70,
Xiap, HTRA, Survivin, Smac, caspase-3, Cytochrome-c, p53, Bax, Bad,
Bid and Bim (Fig. 7A and B).
To confirm and validate the protein array results, the expression
levels of Bax, Bcl-2, caspase-3 and p53 was further determined using
western blot analysis. The results indicate up-regulation of Caspase-3,
Bax and p53, while Bcl-2 showed down-regulation in HCT116wt
(Fig. 7C). p53 has been shown to play a critical role in intrinsic tumor
suppression pathways, via apoptosis induction and cell cycle arrest
pathways (Napoli and Flores, 2017). One of the multiple effects of p53
is to promote apoptosis by disrupting the Bax/Bcl-2 complex and con-
sequent activation of caspase 3. The observed increase in Bax and p53
expression and decrease Bcl-2 expression, provides evidence that the
PSC-hex probably promotes its pro-apoptotic activity by activating the
p53 mediated pro-apoptotic pathway. This assumption is corroborated
by the observed decrease in ΔΨm, a wallmark in p53 mediated in-
duction of apoptosis. For cell cycle arrest, p53 exerts its effects through
Table 1
Identification of the compounds present in P. sajor-caju non-polar extract (relative
abundance %, mean ± standard deviation).
Peak Identification RT (min) LRI Peak Area (%)
1 Tetradecanoic acid (myristic acid;
C14:0)
43.56 1839.14 0.19 ± 0.01
2 D-Mannitol 45.25 1630.50 2.9 ± 0.1
3 Butane 45.38 1738.83 2.67 ± 0.04
4 N-Pentadecanoic acid (C15:0) 45.64 1865.77 3.48 ± 0.09
5 Hexadecanoic acid (palmitic acid,
C16:0)
46.98 2021.41 23.2 ± 0.1
6 (z)-9-octadecenoic acid (oleic
acid, C18:0)
47.34 1980.35 0.32 ± 0.01
7 Octanoic acid (caprylic acid, C8:0) 47.90 2122.40 0.246 ± 0.003
8 9,12-Octadecadienoic acid
(linoleic acid)
48.48 2189.84 24.81 ± 0.03
9 (z)-9,17-Octadecadienal 50.16 2085.69 1.95 ± 0.05
10 Cyclopenta[a.d]cyclo-octen-5-one 50.90 2554.49 0.21 ± 0.01
11 D-(+)-Trehalose 51.52 1940.12 1.34 ± 0.05
12 3,7,11,15-tetramethylhexadeca-
2,6,10,14-tetraen-1-ol
51.98 2506.66 0.391 ± 0.005
13 2-α-Mannobiose 52.20 1955.18 1.25 ± 0.03
14 α-D-Glucopyranosiduronic acid 53.05 1974.00 0.96 ± 0.02
15 9(11)-Dehydroergosteryl benzoate 53.19 3275.92 0.44 ± 0.01
16 3α,5α-Cyclo-ergosta-7,9(11),22-
triene-6β-ol isomer 1
54.57 3194.11 0.220 ± 0.008
17 Ergosta-5,7,9(11),22-tetraen-3-yl
4-methylbenzenesulfonate
54.68 3316.01 0.78 ± 0.03
18 Ergosta-5,7,22-trien-3β-ol 55.43 3338.31 30.6 ± 0.4
19 3β,22E-ergosta-7,22-dien-3 55.51 3225.26 0.99 ± 0.01
20 Cholesta-5,7-dien-3-ol acetate
(3β)
55.90 3340.14 1.28 ± 0.07
21 Cholestan-26-oic acid 56.09 3513.09 1.18 ± 0.03
22 3α,5α-Cyclo-ergosta-7,9(11),22-
triene-6β-ol isomer 2
56.27 3479.49 0.60 ± 0.02
Fig. 8. Representation of Bcl-2 structure with docking conformation of Ergosta-5,7,22-
trien-3β (cyan color, sticks and balls representation) and the co-crystallized inhibitor
Venetoclax (green color, wire representation). Representation prepared using Pymol. (For
interpretation of the references to color in this figure legend, the reader is referred to the
Web version of this article.)
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cyclin-dependent kinase (CDK) inhibitor p21, leading to cell cycle arrest
(Kim et al., 2017). Cell cycle analysis showed that PSC-hex induced cell
cycle arrest at the G2/M phase, suggesting a blockage of cell pro-
liferation of the HCT116wt, which might be regulated by p53 by acti-
vating p21. This assumption is corroborated by the absence of cyto-
toxicity when HTC116-p21, HTC116-p53 and HTC116-Bax cells were used.
3.5. Chemical composition of PSC-hex
Table 1 shows the results regarding the identification and relative
percentage of the twenty-two volatile compounds present in the PSC-
hex. All compounds were identified with tetradecanoic acid (myristic
acid, C14:0), pentadecanoic acid (C15:0), hexadecanoic acid (palmitic
acid, C16:0), 9,12-octadecadienoic acid (linoleic acid, C18:2) and er-
gosta-5,7,22-trien-3β-ol being the main compounds identified in the
extract, with the latter one as most abundant (30.6% of total com-
pounds). These results are in accordance with those previously reported
by others authors studying a similar extract from the Pleurotus ostreatus
(Priya et al., 2012; Mohamed and Farghaly, 2014). Kayode et al. (2015)
identified fatty acids and Usami et al. (2014) other types of compounds,
mainly volatile, in Pleurotus sajor-caju.
3.6. Docking simulation of ergosta-5,7,22-trien-3β against Bcl-2
Bcl-2 is a well-known therapeutic target for anti-tumoral com-
pounds. Known inhibitors promote apoptosis by occupying a hydro-
phobic cleft in the Bcl-2 structural thus preventing binding of Bcl-2 to
pro-apoptotic protein partners including Bax (Radha and Raghavan,
2017). PSC-hex has shown to induce apoptosis by regulating expression
of several apoptotic-related proteins, including down-regulating on of
Bcl-2 expression. However an alternative pathway for inducing apop-
tosis might be accomplished by direct interaction of the compounds
observed in PSC-hex with Bcl-2 (Table 1). Because ergosta-5,7,22-trien-
3β comprises 30% of the extract content, we performed in silico docking
simulations of this compound against Bcl-2, targeting the hydrophobic
interaction cleft. The ergosta-5,7,22-trien-3β docked conformation
fitted nicely in the Bcl-2 hydrophobic cleft, in a similar fashion to Ve-
netoclax, a known Bcl-2 inhibitor (Fig. 8) (Souers et al., 2013), with an
experimental IC50 value of 58 nM and currently in clinical trials against
different types of tumors (Cang et al., 2015). Ergosta-5,7,22-trien-3β
only interacts with a partial section of the hydrophobic cleft, so we do
not expect its inhibition ability to be as high as Venetoclax, still this
docking analysis demonstrate that activation of apoptosis by PSC-hex
may be, at least partially, through direct inhibition of Bcl-2 by ergosta-
5,7,22-trien-3β.
4. Conclusion
PSC-hex was able to generate several molecular responses on
HCT116wt colorectal cancer cell line, such as inducing initial apoptosis
through the intrinsic pathway with upregulation of caspase-3 and Bax,
with cell cycle arrest in G2/M, ROS accumulation and mitochondrial
membrane depolarization. P. sajor-caju can emerge as an important
nutraceutical and pharmacological natural source, in which steroid
compounds appear to play a role on the observed cytotoxic and apop-
totic effects here reported.
Due to the clinical and molecular heterogeneity of CRC, therapeutic
modalities with new approaches to cancer therapy are essential. Many
tumors have defects in activation of apoptosis because of over-
expression of Bcl-2 pro-survival proteins or by inactivation of the p53
pathway (Adams and Cory, 2018). There is evidence that mushroom
extracts have direct cytotoxic effects on cancer cells, which partially
explains the in vivo effect on reducing tumor growth and anti-metastasis
effect (Arata et al., 2016; Tangen et al., 2015). One of the mechanisms
is induction of apoptosis through the mitochondrial pathway, in-
creasing Bax and decreasing Bcl-2 expression (Liang et al., 2014).
Because extracts act on this signaling pathway, nanotechnology can be
used to pack mushroom extracts for more efficient delivery. Another
alternative is dietary supplements in combination with conventional
therapy. The use of combined therapy works on multiple metabolic
pathways: it reduces the development of resistance to anticancer drugs,
increases the sensitivity to the effect of chemotherapeutics, reinforcing
the effectiveness of concentrations and minimizes adverse effects.
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